Cellebrite Pioneers Industry-First Remote Mobile Device Data Collection Solution
PR92006
PETAH TIKVAH, Israel, Sept. 29, 2021 /PRNewswire=KYODO JBN/ --
-- Enterprise Endpoint Intelligence platform unifies remote mobile and
computer data collection for the first-time in one powerful solution that
helps lower corporate risk by strengthening eDiscovery and Corporate
Investigation capabilities
Cellebrite (https://c212.net/c/link/?t=0&l=en&o=3305831-1&h=1228957489&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3254208-1%26h%3D2383684107%26u%3Dhttps%253A%252F%252Fwww.cellebrite.com%252Fen%252Fhome%252F%26a%3DCellebrite&a=Cellebrite) DI, Ltd. (NASDAQ: CLBT) ("Cellebrite"),
a leader in Digital Intelligence (DI)
solutions for the public and private sectors, today announced the release of
remote mobile data collection for Cellebrite Endpoint Inspector, the latest
update of its cloud-first remote collection solution for e-discovery and
corporate investigations. It is the first solution on the market with the
ability to remotely retrieve evidence from iOS and Android mobile devices and
Mac and Windows computers.
Logo -
https://mma.prnewswire.com/media/1637793/Cellebrite_Enterprise_Solutions_Logo.jpg
The introduction of remote mobile device data collection is the latest step in
Cellebrite's effort to address growing enterprise organization needs in
corporate investigations, e-discovery, and incident response with an integrated
Endpoint Intelligence Solution that enhances their ability to take swift action
against threats with industry-leading data collection and analytics
capabilities that are simple, effective, and efficient.
"We focused on simplifying the employee experience during data collection and
deployed our domain expertise to engineer Endpoint Inspector to automate the
complexity of the collection process and limit business interruption," said Ken
Basore, GM Enterprise Solutions, Cellebrite. "In Enterprises that deploy
Endpoint Inspector, employees no longer need to hand over their device or spend
hours with internal support personnel to follow complex procedures. We are
pleased to be able to bring this value to our enterprise customers across life
sciences, banking, insurance, and other industries.
The ability to unify data collection from computers and mobile devices has come
at a critical time for Enterprises, with several emerging trends putting
pressure on corporate investigations and the eDiscovery process:
-- Employees rely on personal devices for work: A third (33%) of people use a
personal device such as a computer or smartphone to facilitate home
working. Cellebrite's new remote mobile collection capability can collect
evidence from devices that are inside or outside of an organization's IT
network, ensuring this vital information doesn't go missing.
-- Critical communication is shifting to messaging apps: 73% of employees
revealed that they use mobile and consumer messaging applications like
WhatsApp for business purposes. Cellebrite's new remote mobile collection
capabilities enable investigators and eDiscovery professionals to collect
this information and create a richer and more complete picture of events.
-- The workforce is increasingly distributed: The rise of remote working has
also led to distributed teams scattered across geographies and locations.
Cellebrite's remote solution decreases the time and financial impact of
collecting data from these employees - cutting out the cost and
inconvenience of shipping or couriering devices to them.
Basore continued, "Corporate investigators are under serious pressure, now
having to face the additional challenge of sourcing data to support cases from
a geographically scattered hybrid workforce, who are using more devices and
messaging services than ever before for professional communications. Today's
announcement underscores the strategic importance of Cellebrite's cloud
capabilities and our commitment to ensure enterprise investigators can adapt to
a hybrid workforce."
Cellebrite has introduced safeguards into the solution, including its Smart
Collections feature, that ensures only information relevant to the
investigation is taken from any device. Employees must provide explicit consent
before their data is collected and a record of this permission is automatically
created as part of the discovery process for audit purposes.
This new solution is available to purchase immediately. For more information,
or to request a solution demo, visit www.cellebrite.com/en/enterprise-solutions.
About Cellebrite
Cellebrite's (Nasdaq: CLBT) mission is to enable its customers to protect and
save lives, accelerate justice, and preserve privacy in communities around the
world. Cellebrite is the global leader in Digital Intelligence solutions for
the public and private sectors, empowering organizations to master the
complexities of legally sanctioned digital investigations by streamlining
intelligence processes. Trusted by thousands of leading agencies and companies
in more than 140 countries, Cellebrite's Digital Intelligence platform and
solutions transform how customers collect, review, analyze and manage data in
legally sanctioned investigations. To learn more visit us at www.cellebrite.com
and https://investors.cellebrite.com.
Caution Regarding Forward Looking Statements
This document includes "forward looking statements" within the meaning of the
"safe harbor" provisions of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements may be identified by the use of
words such as "forecast," "intend," "seek," "target," "anticipate," "believe,"
"could," "continue," "expect," "estimate," "may," "plan," "outlook," "future"
and "project" and other similar expressions that predict, project, or indicate
future events or trends or that are not statements of historical matters. Such
forward looking statements include estimated financial information. Such
forward looking statements with respect to revenues, earnings, performance,
strategies, prospects and other aspects of the business of Cellebrite are based
on current expectations that are subject to risks and uncertainties. A number
of factors could cause actual results or outcomes to differ materially from
those indicated by such forward looking statements. These factors include, but
are not limited to: Cellebrite's ability to develop technologically advanced
solutions and successfully integrate with the software solutions used by
customers; acceptance of solutions by customers; errors, failures, defects or
bugs in solutions; a failure to maintain sales and marketing personnel
productivity or hire, integrate and retain additional sales and marketing
personnel; the impact of the global COVID-19 pandemic; the impact of
competition on pricing and on Cellebrite's market share; sub-optimal results
from products due to misuse by customers; Cellebrite's failure to maintain and
enhance its reputation and brand; inaccuracy of the estimates of Cellebrite's
market opportunity and forecasts of market growth; changes to packaging and
licensing models that adversely affect the ability to attract or retain
customers; failure to manage future growth effectively; failure to introduce
new solutions and add-ons; issues in the use of artificial intelligence
resulting in reputational harm or liability; the need for additional capital to
support the growth of Cellebrite's business; a failure to maintain the security
of operations and the integrity of software solutions; the impact of government
budgeting cycles and appropriations, early termination, audits, investigations,
sanctions and penalties; a decline in government budgets, changes in spending
or budgetary priorities, or delays in contract awards; a failure to adequately
obtain, maintain, protect and enforce Cellebrite's intellectual property or
infringement of the intellectual property rights of others; perceptions or
court or regulatory decisions that Cellebrite's solutions violate privacy
rights; the use of solutions by customers in a way that is, or that is
perceived to be, incompatible with human rights; failure to comply with laws
regarding privacy, data protection and security, technology protection,
sanctions, export controls and other matters; and other factors, risks and
uncertainties set forth in the sections titled "Risk Factors" and "Cautionary
Note Regarding Forward-Looking Statements" in the final proxy
statement/prospectus filed with the SEC on August 5, 2021 and in other
documents filed by Cellebrite with the SEC, which are available free of charge
at www.sec.gov. You are cautioned not to place undue reliance upon any
forward-looking statements, which speak only as of the date made, in this
communication or elsewhere. Cellebrite undertakes no obligation to update its
forward-looking statements, whether as a result of new information, future
developments or otherwise, should circumstances change, except as otherwise
required by securities and other applicable laws.
Media
Adam Jaffe
VP of Global Communications
+1 973 206 7643
adam.jaffe@cellebrite.com - or -
RapidResponse@cellebrite.com
Investors
Anat Earon-Heilborn
VP Investor Relations
+972 73 394 8440
investors@cellebrite.com
SOURCE: Cellebrite
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。